Journal Article (Erratum/Correction)

DKFZ-2022-02907

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

Giardiello, D. ; Hooning, M. J. ; Hauptmann, M. ; Keeman, R. ; Heemskerk-Gerritsen, B. A. M. ; Becher, H. ; Blomqvist, C. ; Bojesen, S. E. ; Bolla, M. K. ; Camp, N. J. ; Czene, K. ; Devilee, P. ; Eccles, D. M. ; Fasching, P. A. ; Figueroa, J. D. ; Flyger, H. ; García-Closas, M. ; Haiman, C. A. ; Hamann, U.DKFZ* ; Hopper, J. L. ; Jakubowska, A. ; Leeuwen, F. E. ; Lindblom, A. ; Lubiński, J. ; Margolin, S. ; Martinez, M. E. ; Nevanlinna, H. ; Nevelsteen, I. ; Pelders, S. ; Pharoah, P. D. P. ; Siesling, S. ; Southey, M. C. ; van der Hout, A. H. ; van Hest, L. P. ; Chang-Claude, J.DKFZ* ; Hall, P. ; Easton, D. F. ; Steyerberg, E. W. ; Schmidt, M. K.

2022
BioMed Central London

This record in other databases:

Please use a persistent id in citations: doi:10.1186/s13058-022-01579-z

---

Contributing Institute(s):

1. Molekulargenetik des Mammakarzinoms (B072)
2. B070 Funktionelle Genomanalyse (B070)
3. C020 Epidemiologie von Krebs (C020)

Research Program(s):

1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2022

---

Database coverage:
; ; ; Article Processing Charges ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Essential Science Indicators ; Fees ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---